Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

[1]  Orton,et al.  INTRAVENOUS NESIRITIDE, A NATRIURETIC PEPTIDE, IN THE TREATMENT OF DECOMPENSATED CONGESTIVE HEART FAILURE , 2000 .

[2]  H. Eiskjaer,et al.  Renal effects of brain natriuretic peptide in patients with congestive heart failure. , 1999, Clinical science.

[3]  M. Packer,et al.  Sudden unexpected death in patients with congestive heart failure: a second frontier. , 1985, Circulation.

[4]  K. Araki.  [Mental health activities for evacuees of the volcanic eruption of Mt. Unzen-Fugen--crisis intervention of a psychiatrist]. , 1995, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[5]  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). , 1995, Circulation.

[6]  W. Vollmer,et al.  Psychiatric reactions to disaster: the Mount St. Helens experience. , 1986, The American journal of psychiatry.

[7]  R. Bain,et al.  Effects of vesnarinone on morbidity and mortality in patients with heart failure , 1993 .

[8]  C. North.  The course of post-traumatic stress disorder after the Oklahoma City bombing. , 2001, Military medicine.

[9]  M. Packer,et al.  Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure. , 1984, American Journal of Cardiology.

[10]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[11]  T. MacDonald,et al.  Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. , 1996, Circulation.

[12]  S. Galea,et al.  Psychological sequelae of the September 11 terrorist attacks in New York City. , 2002, The New England journal of medicine.

[13]  D. G. Watts,et al.  Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. , 1983, British journal of clinical pharmacology.

[14]  J. Farmer,et al.  Specialized delivery systems for intravenous nitroglycerin. Are they necessary? , 1984, The American journal of medicine.

[15]  B. Heintz,et al.  Clinical pharmacokinetics of vasodilators. Part II. , 1998, Clinical pharmacokinetics.

[16]  R. Hobbs,et al.  Therapeutic potential of nesiritide (recombinant b-type natriuretic peptide) in the treatment of heart failure. , 1999, Expert opinion on investigational drugs.

[17]  C. Lazzeri,et al.  [Brain natriuretic peptide]. , 1995, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

[18]  J. Rouleau,et al.  The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. , 1993, The Canadian journal of cardiology.

[19]  송광엽.  Oregon Health Sciences Umversity 치과대학을 다녀와서 , 1997 .

[20]  M. Elliott,et al.  A national survey of stress reactions after the September 11, 2001, terrorist attacks. , 2001, The New England journal of medicine.

[21]  D. P. White.  Tragedy and insomnia. , 2001, The New England journal of medicine.

[22]  J. Rouleau,et al.  Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. , 1990, American heart journal.

[23]  M. Redfield,et al.  Subcutaneous administration of brain natriuretic peptide in experimental heart failure. , 2000, Journal of the American College of Cardiology.

[24]  E. Bennett,et al.  The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure , 1985, Intensive Care Medicine.

[25]  M A Konstam,et al.  Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. , 1995, Journal of cardiac failure.

[26]  K. Dickstein,et al.  Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure. , 1997, American heart journal.